(Sharecast News) - AOTI announced on Tuesday that it has secured inclusion of its Topical Wound Oxygen (TWO2) therapy in the NHS Supply Chain framework agreement for advanced wound care, effective from 1 September.
The AIM-traded firm said the decision followed the publication of a peer-reviewed health economic study which concluded...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE